---

Bill Title: To amend the Orphan Drug Act to reauthorize a program of grants and contracts for the development of drugs for rare diseases and conditions (commonly referred to as "orphan drugs").

Spectrum: Bipartisan Bill

Status: (Introduced - Dead) 2022-05-03 - Referred to the House Committee on Energy and Commerce. [HB7640 Detail]

Download: US_Congress-2021-HB7640-Introduced.pdf

---